Prevalence and Burden of Bronchiectasis in Tuberculous Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-09-26

Study Completion Date

2020-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Bronchiectasis was described in the early 19th century by Laennec. Bronchiectasis is a chronic condition characterized by permanent and irreversible dilatation of the bronchial airways and impairment of mucociliary transport mechanism due to repeated infection and inflammation leading to colonization of organism and pooling of the mucus in the bronchial tree

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Different Phenotypes of Bronchiectasis

NCT03262064

Bronchiectasis

TERMINATED

Prevalence of Bronchiectasis in COPD Patients

NCT04101448

Bronchiectasis Chronic Obstruct Airways Disease Prognosis

UNKNOWN

Natural History of Bronchiectasis

NCT00943514

Bronchiectasis Cystic Fibrosis Autoimmune Disease +1 more

RECRUITING

Bronchiactasis as Atypical Presentation in COVID-19

NCT04910113

Covid19 in Bronchiactasis

UNKNOWN

Cross-sectional Characterization of Idiopathic Bronchiectasis

NCT01264055

Infection Bronchial Diseases Respiratory Tract Diseases

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Bronchiectasis was described in the early 19th century by Laennec. Bronchiectasis is a chronic condition characterized by permanent and irreversible dilatation of the bronchial airways and impairment of mucociliary transport mechanism due to repeated infection and inflammation leading to colonization of organism and pooling of the mucus in the bronchial tree.

The prevalence of bronchiectasis is age-related and occurs in every age group and in the pre-antibiotic era . it most often began in childhood. Recent evidence shows that bronchiectasis disproportionately affects women and older individuals and will be contributing to increase in healthcare burden.\[3\] International data show an increase in the prevalence of bronchiectasis over recent years.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Tuberculoses

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Gene Xpert Chest x ray and MSCT chest

Sputum sample for T.B will be done using gene expert device and chest xray and high resolution ct to evaluate bronchectasis

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1-patients were diagnosed to have tuberculosis by sputum culture and gene x pert.

2-patients were diagnosed to have bronchiectasis after lab and radiological examination as well as clinical score.

3- patients diagnosed as bronchiectasis after history of tuberculosis or anti Tuberculosis treatment with positive or negative tuberculous culture in the time of research.

Exclusion Criteria

* 1-patients presented with other Pulmonary diseases. 2-Chronic liver and renal disease . 3- Lung cancer and tumors. 4- patients were previously diagnosed as bronchiectasis .

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No